{"status": "ok", "totalResults": 2, "articles": [{"source": {"id": "ars-technica", "name": "Ars Technica"}, "author": "Andrew Cunningham", "title": "What I learned from 3 years of running Windows 11 on \u201cunsupported\u201d PCs - Ars Technica", "description": "When your old PC goes over the Windows 10 update cliff, can Windows 11 save it?", "url": "https://arstechnica.com/gadgets/2024/10/what-i-learned-from-3-years-of-running-windows-11-on-unsupported-pcs/", "urlToImage": "https://cdn.arstechnica.net/wp-content/uploads/2024/10/IMG_2251-1-1152x648.jpeg", "publishedAt": "2024-10-25T10:45:41Z", "content": null}, {"source": {"id": null, "name": "FierceBiotech"}, "author": "Darren Incorvaia", "title": "Eisai, Eli Lilly didn\u2019t disclose heightened brain injury risk to Alzheimer\u2019s trial patients: NYT - Fierce Biotech", "description": "A new bombshell has been dropped in the scandal-plagued world of Alzheimer\u2019s disease drug development. | Between the two companies, more than 560 people joined trials without being told they had a heightened risk of dangerous side effects such as brain bleedi\u2026", "url": "https://www.fiercebiotech.com/cro/eisai-and-eli-lilly-didnt-disclose-genetic-results-indicating-high-risk-alzheimers-trial", "urlToImage": "https://qtxasset.com/quartz/qcloud5/media/image/GettyImages-486932896.jpg?VersionId=6hnkBOX0hOEVds.nhFFvfjrYC.Ih1pex", "publishedAt": "2024-10-24T15:33:40Z", "content": null}]}